A study in human patients with heart failure after acute myocardial infarction demonstrated that the miR-543 was significantly upregulated in peripheral blood mononuclear cells from individuals exhibiting sacubitril/valsartan resistance compared to non-resistant patients, as validated by quantitative real-time PCR [Su et al. DOI:10.1016/j.ejphar.2023.175547]. A study in rhesus macaques demonstrated that the miR-543 was utilized in a model to predict the future development of pleural effusion following whole thorax irradiation, achieving high accuracy in a Day 15 prediction model [May et al. DOI:10.1038/s41598-022-16316-x].